Anti – Allergy EpiPens Recalled Due To Activation Failure

A recall of EpiPen and EpiPen Jr. injectors has been extended to the U.S. due to activation failure that might cause health problems during a life - threatening allergic reaction.

According to the FDA, Meridian Medical Technologies has expanded a voluntary recall of select lots of EpiPen and EpiPen Jr®  Auto-Injectors to now include additional lots distributed in the U.S. and other markets due to  reports outside of the U.S. of failure to activate the device due to a potential defect in a supplier component. The potential defect could make the device difficult to activate in an emergency and have significant health consequences for a patient experiencing a life-threatening allergic reaction (anaphylaxis).

To return your product please contact Stericycle at 877-650-3494. If you have any additional questions regarding this recall, please contact Mylan Customer Relations at 800-796-9526 or customer.service@mylan.com.